Protective effect of hydrogen sulfide on TNF-α and IFN-γ-induced injury of intestinal epithelial barrier function in Caco-2 monolayers

Inflammation Research

Volumn 64, Issue 10, 2015, Pages 789-797

  Chen, Shan Wen ^a   Zhu, Jing ^a   Zuo, Shuai ^a   Zhang, Jun Ling ^a   Chen, Zi Yi ^a   Chen, Guo Wei ^a   Wang, Xin ^a   Pan, Yi Sheng ^a   Liu, Yu Cun ^a   Wang, Peng Yuan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

H2S; MLCK; NF kB; Tight junction; ZO 1

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GAMMA INTERFERON; HYDROGEN SULFIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOSIN LIGHT CHAIN; OCCLUDIN; PROTECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; MYOSIN LIGHT CHAIN KINASE; TIGHT JUNCTION PROTEIN; TRANSCRIPTION FACTOR RELA;

ARTICLE; CACO 2 CELL LINE; CELL DAMAGE; CONTROLLED STUDY; DRUG MECHANISM; ELECTRIC RESISTANCE; GEL MOBILITY SHIFT ASSAY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INTESTINAL EPITHELIAL BARRIER FUNCTION INJURY; INTESTINE INJURY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH PROTECTION; TRANS EPITHELIAL ELECTRICAL RESISTANCE; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; EPITHELIUM; HUMAN; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PHOSPHORYLATION; STOMACH ULCER;

BIOMARKERS; CACO-2 CELLS; EPITHELIUM; HUMANS; HYDROGEN SULFIDE; INTERFERON-GAMMA; INTESTINAL MUCOSA; MYOSIN LIGHT CHAINS; MYOSIN-LIGHT-CHAIN KINASE; OCCLUDIN; PHOSPHORYLATION; STOMACH ULCER; TIGHT JUNCTION PROTEINS; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941420365     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-015-0862-5     Document Type: Article

References (40)

1. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9(11):799–809.
2. Lin N, Xu LF, Sun M. The protective effect of trefoil factor 3 on the intestinal tight junction barrier is mediated by toll-like receptor 2 via a PI3 K/Akt dependent mechanism. Biochem Biophys Res Commun. 2013;440(1):143–9.
3. Chen SW, Wang PY, Zhu J, Chen GW, Zhang JL, Chen ZY, Zuo S, Liu YC, Pan YS. Protective effect of 1,25-Dihydroxyvitamin D3 on lipopolysaccharide-induced intestinal epithelial tight Junction injury in Caco-2 cell monolayers. Inflammation. 2014;38:375e383.
4. Chen S, Zhu J, Chen G, Zuo S, Zhang J, Chen Z, et al. 1,25-Dihydroxyvitamin D3 preserves intestinal epithelial barrier function from TNF-α induced injury via suppression of NF-kB p65 mediated MLCK-P-MLC signaling pathway. Biochem Biophys Res Commun. 2015;. doi:10.1016/j.bbrc.2015.03.125(Epub ahead of print).
5. Zanardo RC, Brancaleone V, Distrutti E, et al. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006;20:2118–20.
6. Du J, Huang Y, Yan H, Zhang Q, Zhao M, et al. Hydrogen sulfide suppresses oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κB (NF-κB) pathway. J Biol Chem. 2014;289(14):9741–53.
7. Wallace JL, Vong L, McKnight W, Dicay M, Martin GR. Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats. Gastroenterology. 2009;137(2):569–78.
8. Flannigan KL, Agbor TA, Blackler RW, Kim JJ, Khan WI, Verdu EF, et al. Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis. Proc Natl Acad Sci U S A. 2014;111(37):13559–64.
9. Medani M, Collins D, Docherty NG, Baird AW, O’Connell PR, Winter DC. Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflamm Bowel Dis. 2011;17(7):1620–5.
10. Ye D, Guo S, Al-Sadi R, Ma TY. MicroRNA regulation of intestinal epithelial tight junction permeability. Gastroenterology. 2011;141(4):1323–33.
11. Puthia MK, Sio SW, Lu J, Tan KS. Blastocystis ratti induces contact- independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells. Infect Immun. 2006;74:4114.
12. Ma TY, Hoa NT, Tran DD, Bui V, Pedram A, Mills S, Merryfield M. Cyto- chalasin B modulation of Caco-2 tight junction barrier: role of myosin light chain kinase. Am. J. Physiol. Gastrointest. Liver Physiol. 2000;279:875e885.
13. Ma TY, Nguyen D, Bui V, et al. Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol. 1999;276:965e974.
14. Guo S, Al-Sadi R, Said HM, Ma TY. Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enter- ocyte membrane expression and localization of TLR-4 and CD14. Am. J. Pathol. 2013;182:375.
15. Schlegel N, Meir M, Spindler V, Germer CT, Waschke J. Differential role of RhoGTPases in intestinal epithelial barrier regulation in vitro. J Cell. Physi- ology. 2011;226:1196e1203.
16. Schliwa M. Action of cytochalasin D on cytoskeletal networks. J Cell Biol. 1982;92:79e91.
17. Siddiqui MR, Mayanil CS, Kim KS, Tomita T. Angiopoietin-1 Regulates Brain Endothelial Permeability through PTPN-2 Mediated Tyrosine Dephosphorylation of Occludin. PLoS ONE. 2015;10(6):e0130857.
18. Qasim M, Rahman H, Ahmed R, Oellerich M, Asif AR. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions Exp. Cell. Res. 2014;322:277e289.
19. Shen L, Black ED, Witkowski ED, Lencer WI, Guerriero V, Schneeberger EE, Turner JR. Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure. J. Cell. Sci. 2006;119:2095e2106.
20. Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta induced increase in intestinal epithelial tight junction permeability. J. Immunol. 2008;180:5653e5661.
21. Clayburgh DR, Barrett TA, Tang Y, Meddings JB, Van Eldik LJ, Watterson DM, Clarke LL, Mrsny RJ, Turner JR. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation- induced diarrhea in vivo. J. Clin. Invest. 2005;115:2702e2715.
22. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol. 2005;288(3):G422–30.
23. Cunningham KE, Turner JR. Myosin light chain kinase: pulling the strings of epithelial tight junction function. Ann N Y Acad Sci. 2012;1258:34–42.
24. Ye D, Ma I, Ma TY. Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol. 2006;290(3):G496–504.
25. Cao H, Zhou X, Zhang J, et al. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance. Toxicol Lett. 2014;224(3):387–94.
26. Rao RK, Basuroy S, Rao VU, Karnaky KJ Jr, Gupta A. Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem J. 2002;368(Pt 2):471–81.
27. Elias BC, Suzuki T, Seth A, Giorgianni F, Kale G, Shen L, et al. Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J Biol Chem. 2009;284(3):1559–69.
28. Murakami T, Felinski EA, Antonetti DA. Occludin phosphorylation and ubiquitination regulate tight junction trafficking and vascular endothelial growth factor-induced permeability. J Biol Chem. 2009;284(31):21036–46.
29. Fiorucci S, Distrutti E, Cirino G, Wallace JL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology. 2006;131(1):259–71.
30. Zanardo RC, Brancaleone V, Distrutti E, et al. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J. 2006;20:2118–20.
31. Wallace JL, Dicay M, McKnight W, et al. Hydrogen sulfide enhances ulcer healing in rats. FASEB J. 2007;21:4070–6.
32. Wallace JL, Blackler RW, Chan MV, et al. Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics. Antioxid Redox Signal. 2015;22:398–410.
33. Cao M, Wang P, Sun C, He W, Wang F. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway. PLoS ONE. 2013;8(5):e61944.
34. Cheadle GA, Costantini TW, Lopez N, Bansal V, Eliceiri BP, Coimbra R. Enteric glia cells attenuate cytomix-induced intestinal epithelial barrier breakdown. PLoS ONE. 2013;8(7):e69042.
35. Ye D, Ma TY. Cellular and molecular mechanisms that mediate basal and tumor necrosis factor-a induced regulation of myosin light chain kinase gene activity. J. Cell. Mol. Med. 2008;12:1331.
36. Boivin MA, Ye D, Kennedy JC, Al-Sadi R, Shepela C, Ma TY. Mechanism of glucocorticoid regulation of the intestinal tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 2007;292:590e598.
37. Moriez R, Salvador-Cartier C, Theodorou V, Fioramonti J, Eutamene H, Bueno L. Myosin light chain kinase is involved in lipopolysaccharide-induced disruption of colonic epithelial barrier and bacterial translocation in rats. Am. J. Pathol. 2005;167:1071e1079.
38. Ma TY, Boivin MA, Ye D, Pedram A, Said HM. Mechanism of TNF-{alpha} modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. Am J Physiol Gastrointest Liver Physiol. 2005;288(3):G422–30.
39. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, Said HM. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 2004;286(3):G367–76.
40. Guo C, Liang F, Shah Masood W, Yan X. Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway. Eur J Pharmacol. 2014;725:70–8.